Image (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 01)
Amlodipine Besylate Tablet
Product Images NDC 82009-028
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 82009-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image2 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 02)
This appears to be a section of a medical or scientific report discussing an event rate and related statistics. The P-value is 0.003, the hazard ratio is 0.691, and the 95% confidence interval ranges from 0.54 to 0.88. There is also a chart with time in months and a reference to Amlodipine, a medication used to treat high blood pressure. However, the context and purpose of the study are not clear from this limited text.*
Image3 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 03)
This appears to be a table containing statistical data related to a medical study involving a drug called Amlodipine and a placebo. The data is organized by age, gender, blood pressure, vessel disease, and stent placement. The table includes the number of participants in each group and various measurements such as mean sitting systolic blood pressure. Additional information is not available.*
1 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 04)
Each tablet contains Amlodipine besylate USP equivalent, manufactured by Cipla Ltd. The tablets are dispensed in tight, light-resistant containers, and should be stored in a controlled room temperature. The usual dosage should be seen in the accompanying prescribing information. Please refer to the Patient Leaflet for further instructions. Batch overprinting includes Serial No., Expiry & Lot. PHARMACIST: ExP will be overprinted during commercial packing.*
2 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 05)
Each tablet contains Amlodipine besylate USP 5 mg. It is manufactured by Cpla Ltd in Verna Goa, India and sold under the brand name Quallent. The usual dosage is specified in the accompanying prescribing information. The tablets should be stored in a tight, light-resistant container at room temperature and protected from light and moisture. The patient leaflet should be dispensed with the medicine. Batch details including serial number, expiry, and lot numbers will be overprinted during commercial packing.*
3 (C45b7a8d 29fb 44b3 929d 8c6e2a41ff11 06)
This appears to be the description of a medication named Amlodipine Besylate, in the form of 1000 tablets per container, with a concentration of 1 mg. The manufacturer is Cila Ltd. and the product is being manufactured for Qualent. The text also provides the National Drug Code (NDC) of 62000-028-10, and some instructions for storage and dispensing of the medication. There is a reference to "accompanying Grand Cayman, Cayman Islands prescribing information," but it is unclear what this refers to.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
